Immatics at the Cell & Gene Therapy Bioprocessing & Commercialization 2018 (Sept 4-7) in Boston, MA

| News, USA

We are happy to announce, that Immatics will attend the Cell & Gene Therapy Bioprocessing & Commercialization on Sept 4-7 in Boston. If you're there, discuss with Ali Mohamed (Vice President CMC, Immatics US) Immatics' Adoptive Cell Therapy approach. Don't miss out!

 

September 6th

10:30am-11:00am

"Adopting Various Manufacturing Closed Systems to Gene Modified T Cell Therapies

Speaker: Ali Mohamed (Vice President CMC, Immatics US)

Session: "Bioprocessing"

 

11:30am-12:00pm

Plenary Session: "Monitoring Quality Across the Process – Process and Automated Analytics for Cell Therapies

Chair: Ali Mohamed (Vice President CMC, Immatics US)

 

5:00pm-6:00pm

Poster: "The ACTolog® Approach: Multi-target Adoptive Cell Therapy using Endogenous Antigen Specific T cells

Presenter: Ali Mohamed (Vice President CMC, Immatics US)

 

We're looking forward to interesting and exciting discussions.

Further information on Cell & Gene Therapy Bioprocessing & Commercialization here.

Press Contact

Dr Nikola Wiegeler

Press contact,
Immatics Biotechnologies GmbH

+49 7071 5397-0

Go back